164 related articles for article (PubMed ID: 27753794)
1. Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China.
Zhu F; Deckx H; Roten R; Michiels B; Sarnecki M
Pediatr Infect Dis J; 2017 Jan; 36(1):94-101. PubMed ID: 27753794
[TBL] [Abstract][Full Text] [Related]
2. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults.
Rebedea I; Diaconescu IG; Bach D; Bartelsen O; Arndtz N
Vaccine; 2006 Jun; 24(25):5320-6. PubMed ID: 16707195
[TBL] [Abstract][Full Text] [Related]
3. The safety and immunogenicity of two hepatitis B vaccine formulations (thiomersal-free and thiomersal-containing) in healthy vietnamese infants: a phase III, prospective, single-blinded, randomized, controlled trial.
Hieu NT; Sarnecki M; Tolboom J
Pediatr Infect Dis J; 2015 Jan; 34(1):79-83. PubMed ID: 25036048
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years.
Hieu NT; Kim KH; Janowicz Z; Timmermans I
Vaccine; 2002 Mar; 20(13-14):1803-8. PubMed ID: 11906768
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
[TBL] [Abstract][Full Text] [Related]
6. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
[TBL] [Abstract][Full Text] [Related]
9. The immunogenicity in healthy infants and efficiency to prevent mother to child transmission of Hepatitis B virus of a 10μg recombinant yeast-derived Hepatitis B vaccine (Hep-KSC).
Zhu FC; Sun KX; Pan HX; Yang ZH; Lu Y; Liang ZL; Liang XF; Wang FZ; Zeng Y; Li J
Vaccine; 2016 May; 34(24):2656-62. PubMed ID: 27113166
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.
Velu V; Nandakumar S; Shanmugam S; Jadhav SS; Kulkarni PS; Thyagarajan SP
World J Gastroenterol; 2007 Jun; 13(22):3084-9. PubMed ID: 17589924
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
Kang G; Ma F; Chen H; Yang Y; Guo S; Wang Z; Liang X; Li L; Cui F; Zhang L
Vaccine; 2015 Aug; 33(33):4093-9. PubMed ID: 26144895
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
[TBL] [Abstract][Full Text] [Related]
13. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
Keating GM; Noble S
Drugs; 2003; 63(10):1021-51. PubMed ID: 12699402
[TBL] [Abstract][Full Text] [Related]
14. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B.
Martins RM; Bensabath G; Arraes LC; Oliveira Mde L; Miguel JC; Barbosa GG; Camacho LA
Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):865-71. PubMed ID: 15761604
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927
[TBL] [Abstract][Full Text] [Related]
17. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
18. Effect of revaccination using different schemes among adults with low or undetectable anti-HBs titers after hepatitis B virus vaccination.
Lin CS; Xie SB; Liu J; Zhao ZX; Chong YT; Gao ZL
Clin Vaccine Immunol; 2010 Oct; 17(10):1548-51. PubMed ID: 20719983
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.
Coates T; Wilson R; Patrick G; André F; Watson V
Clin Ther; 2001 Mar; 23(3):392-403. PubMed ID: 11318074
[TBL] [Abstract][Full Text] [Related]
20. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]